# Eli Lilly and Company (LLY) — Q4-2013 Earnings Results

**Report date:** 2014-01-30 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q4-2013

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Down 1.19%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.74 | N/A | +0.82% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based on numerical results only.

### Guidance Changes

No guidance data is available.

### What It Means

Eli Lilly reported an EPS of $0.74, which was a slight beat, but the stock reacted negatively, declining by 1.19%. The lack of revenue data and management commentary may have contributed to investor uncertainty. Overall, the mixed results suggest cautious sentiment among investors.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q4-2013_